Summary
• Sight Sciences, Inc. (SGHT) shares rose 5.9% in after-hours trading to $8.88 following strong quarterly results.
• Q3 reported a net loss of $0.16 per share, beating consensus estimates of a $0.26 loss, with improved revenue guidance for 2025.
• Insider Taylor Brenton sold shares, indicating executive confidence in the company’s financial health and future prospects.
Sight Sciences, Inc. (NASDAQ: SGHT) saw a robust after-hours increase of 5.9%, bringing its current price to $8.88, up from the last close of $8.39. This move indicates a positive reaction, although it occurred without a fresh catalyst.
Q3 Financial Results Drive Momentum
In its recent third-quarter report, Sight Sciences increased its revenue guidance and reduced its adjusted operating expense forecast for the full year 2025. The Q3 results reflected a net loss of $0.16 per share, a notable surprise since the consensus estimate was a loss of $0.26, suggesting a 38% positive surprise. These results and updates signal the company’s continued focus on innovative eye care technologies that aim to improve patient outcomes.
Insider Transactions Highlight Confidence
In a noteworthy insider transaction, Taylor Brenton, EVP of Operations & R&D, sold 14,418 shares at a cost of $7.06 each on November 17, 2025. This transaction valued at approximately $101,791, reflects the confidence of company executives in the financial stability and future direction of the organization.
Market and Technical Picture
Current trading metrics indicate a solid performance backdrop for SGHT. The stock’s 14-day RSI sits at a high 77.08, implying it may be approaching overbought territory. The average volume over the last 10 days is 217,930, with a recent trading volume of 17,610, suggesting healthy investor interest. Meanwhile, the stock’s annual performance stands at an impressive 24.9%, backed by a strong monthly uptick of 72.2%.
Closing Thoughts
As the market responds to Sight Sciences’ latest financial results and updated forecasts, traders are likely to monitor how the stock’s momentum carries into the next session. With strong quarterly performance, the outlook remains focused on the company’s growth trajectory, even as it navigates routine trading conditions.